Notice ID: a3117503ada54e8c91724b1d8ad25f0bCombined Synopsis/Solicitation
3D Bioprinting Station
Archived on September 21, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−04:00
- Posted
- August 26, 2022
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- 75N95022Q00443
- Notice ID
- a3117503ada54e8c91724b1d8ad25f0b
Description
The 3D Tissue Bioprinting Laboratory (3DTBL) at the National Center for Advancing Translational Sciences (NCATS) is producing and using engineered tissues as physiological relevant assay platforms for predictive drugs screening. There is a need to purchase a new bioprinter which will be used to increase the capabilities of the group to develop biofabricated tissue models, including neuronal circuits of addiction and pain (HEAL program), neuromuscular junction (NMJ) tissue for muscular dystrophy-related diseases (potential application for gene therapy, like congenital myasthenic syndrome (CMS) for PaVe-GT program), and pain (HEAL program), vascularized lung models for the Antiviral Pandemic Program (APP), and tissue for the two programs funded by the RFA-TR-21-015. The purpose of this acquisition is to acquire one (1) of Regenhu’s 3D Bioprinting Station model R-GEN 200 or Equal that meet all salient characteristics.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Valerie Whipple
Documents
No documents available.
Lifecycle
Solicitation:
75N95022Q00443- Combined Synopsis
- 2×Combined SynopsisCurrentAug 23, 2022
3D Bioprinting Station
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95022Q00443
Archive Date
Sep 21, 2022
Office Address
Bethesda, MD, 20892